June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Different Association of ARMS2, CFH, CFHR1-3, SERPINF1, VEGFR1 and C5 Polymorphisms in response of Ranibizumab treatment in wet-AMD.
Author Affiliations & Notes
  • Alvaro Velazquez Villoria
    Ophthalmology, Clinica Universidad de Navarra, Pamplona, Spain
    Ophthalmology Research Laboratory, University of Navarra, Pamplona, Spain
  • Sergio Recalde
    Ophthalmology Research Laboratory, University of Navarra, Pamplona, Spain
  • Patricia Fernandez-Robredo
    Ophthalmology Research Laboratory, University of Navarra, Pamplona, Spain
  • Carla Barreales
    Ophthalmology, Hospital Virgen del Camino, Pamplona, Spain
  • Esefanía Cobos
    Ophthalmology, Hospital Bellvitge, Barcelona, Spain
  • Alicia Valverde
    Ophthalmology, Hospital Clínico de Madrid, Madrid, Spain
  • Marta Suarez-Figueroa
    Ophthalmology, Hospital Ramón y Cajal, Madrid, Spain
  • Fernando Cruz
    Ophthalmology, Complejo asistencial Universitario de Salamanca, Salamanca, Spain
  • Maximino Abraldes
    Ophthalmology, Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain
  • Alfredo Garcia Layana
    Ophthalmology, Clinica Universidad de Navarra, Pamplona, Spain
    Ophthalmology Research Laboratory, University of Navarra, Pamplona, Spain
  • Footnotes
    Commercial Relationships Alvaro Velazquez Villoria, None; Sergio Recalde, None; Patricia Fernandez-Robredo, None; Carla Barreales, None; Esefanía Cobos, None; Alicia Valverde, None; Marta Suarez-Figueroa, None; Fernando Cruz, None; Maximino Abraldes, None; Alfredo Garcia Layana, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3787. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alvaro Velazquez Villoria, Sergio Recalde, Patricia Fernandez-Robredo, Carla Barreales, Esefanía Cobos, Alicia Valverde, Marta Suarez-Figueroa, Fernando Cruz, Maximino Abraldes, Alfredo Garcia Layana; Different Association of ARMS2, CFH, CFHR1-3, SERPINF1, VEGFR1 and C5 Polymorphisms in response of Ranibizumab treatment in wet-AMD.. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3787.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine if prespecified genetic single nucleotide polymorphisms (SNPs) influence responsiveness to vascular endothelial growth factor (VEGF) inhibition by Ranibizumab in neovascular age-related macular degeneration (AMD) in Spanish patients.

Methods: A cohort of 400 Caucasian patients with unilateral exudative AMD<br /> received intravitreal ranibizumab. After a three-injection loading phase, a PRN<br /> regimen was followed. Thirteen SNPs of 8 genes (CFH, CFHR1-3, CFB, ARMS2, C5, SERPINF1, VEGFR1, VEGF) were genotyped to evaluate their influence in the response to Ranibizumab. Non-genetic risk factors, (gender, smoking habit, and hypertension) were considered. The classification of good/bad responder was made using functional (visual acuity measured by ETDRS), anatomical (liquid/no liquid measured by OCT) and number of injections criteria. The genotyping was performed using multiplex PCR and primer extension methodology in a 3730 automated sequencer. All the polymorphisms analyzed in this report were in Hardly-Weingberg equilibrium.

Results: rs10490924/ARMS2 and rs12603486/SERPINF1 each independently influenced (p<0.05) treatment response in functional and anatomical criteria while rs388862/CFHR1-3 showed influence (p<0.05) in anatomical and number of injection criteria. rs800292/CFH and rs7993418/VEGFR1 for anatomical criterion and rs1136287/SERPINF1, rs17611/C5 and smoking habit for number of injection criterion showed a significant association (p<0.05) with the treatment response.

Conclusions: ARMS2, CFH, CFHR1-3, SERPINF1, VEGFR1 and C5 risk or protective alleles and smoking habit affect the response to Ranibizumab in wet AMD. In addition, ARMS2, SERPINF1 and CFHR1-3 alleles have showed their response influence in more than one response evaluation criteria (Functional, anatomical or number of injection).

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×